WEBSITECHANGES

Website Changes

---

07/29/2019

Dramatic response of BRAF V600E-mutant epithelioid glioblastoma to combination therapy with BRAF and MEK inhibitor: establishment and xenograft of a cell line to predict clinical efficacy.

---

07/29/2019

Long-term survival in patients with recurrent glioblastoma treated with bevacizumab: a multicentric retrospective study.

---

07/29/2019

Valerie Harper to stay out of hospice care, husband says

---

07/26/2019

Musella Foundation Brain Tumor Copay Program has reopened!

---

07/20/2019

A Randomized Double-Blind Placebo-Controlled Phase 2 Trial Of Dendritic Cell Vaccine ICT-107 In Newly Diagnosed Patients With Glioblastoma

---

07/19/2019

Study hints at why an aggressive form of brain cancer is hard to treat

---

07/19/2019

A New Method for Ethical and Efficient Evidence Generation for Off-Label Medication Use in Oncology (A Case Study in Glioblastoma)

---

07/18/2019

Medicare Releases Final Local Coverage Determination Providing Coverage of Optune® for Newly Diagnosed Glioblastoma

---

07/17/2019

ImmunoCellular Therapeutics Announces Asset Purchase Agreement with Private Biotechnology Company

---

07/17/2019

Electricity helps control man’s brain tumor

---

07/16/2019

GBM Awareness Day This Wednesday July 17th!

---

07/16/2019

Neoadjuvant Anti-PD-1 Immunotherapy Leads to Survival Benefit in Recurrent Glioblastoma

---

07/16/2019

Attend an Optune Open House.

---

07/15/2019

Phase II study of Dovitinib in recurrent glioblastoma.

---

07/06/2019

Insurance type impacts the economic burden and survival of patients with newly diagnosed glioblastoma.

---

07/01/2019

Defeat DIPG Executive Director Jenny Mosier Speaks at FDA Public Hearing Regarding ONC201

---

06/25/2019

Integrating Clinical Research And Care In A Perpetual Trial

---

06/24/2019

Musella Foundation awards 9 grants!

---

06/22/2019

Medicenna Presents Preliminary Top-Line Clinical Results from their Phase 2b Trial of MDNA55 in Recurrent Glioblastoma

---

06/22/2019

New Data Demonstrates Safety Profile of GammaTile Therapy for Various Brain Tumors

---

06/22/2019

Bayer’s regorafenib kicks off brain cancer platform trial

---

06/13/2019

Webinar: Personalized Approaches to Treating Cancer Explained in Plain Language

---

06/12/2019

Glioblastoma Awareness Day Resolution Passes U.S. Senate with Unanimous Support

---

06/11/2019

Oncology Expert Keith T. Flaherty, MD Named Chairman of xCures Scientific Advisory Board

---

06/10/2019

Attend an Optune Open House.

---